Philips ventilator recall classified as most serious by USFDA

Published On 2021-07-23 10:28 GMT   |   Update On 2021-11-22 15:54 GMT
Advertisement

New Delhi: The U.S. Food and Drug Administration on Thursday classified the recall of Philips' breathing devices and ventilators as Class 1, or the most serious type of recall, saying the use of these devices may cause serious injuries or death.

The agency said there have been 83 complaints regarding the products used to provide breathing assistance, but no injuries or deaths were reported for these issues.

Advertisement

Read also: Cadila Healthcare arm recalls Metformin Hydrochloride ER tablets in US

The Dutch medical equipment company recalled some of its breathing devices and ventilators in June, as the foam used to dampen the machines' sound could degrade and emit small particles that irritate airways. The gases released may also be toxic or carry cancer risks, Philips had said.

Read also: Trouble for JnJ: Carcinogen found in some Aveeno, Neutrogena sunscreens, products recalled



Tags:    
Article Source : Reuters

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News